ArticleFrontiers in oncology2026

HAIC combined with atezolizumab and bevacizumab versus lenvatinib in advanced hepatocellular carcinoma: a multicenter propensity score matching analysis.

Lei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.